A detailed history of Springhill Fund Asset Management (Hk) CO LTD transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Springhill Fund Asset Management (Hk) CO LTD holds 116,400 shares of BCYC stock, worth $1.46 Million. This represents 2.65% of its overall portfolio holdings.

Number of Shares
116,400
Holding current value
$1.46 Million
% of portfolio
2.65%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$13.81 - $27.5 $1.61 Million - $3.2 Million
116,400 New
116,400 $1.63 Billion

Others Institutions Holding BCYC

About BICYCLE THERAPEUTICS plc


  • Ticker BCYC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,676,100
  • Market Cap $372M
  • Description
  • Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...
More about BCYC
Track This Portfolio

Track Springhill Fund Asset Management (Hk) CO LTD Portfolio

Follow Springhill Fund Asset Management (Hk) CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Springhill Fund Asset Management (Hk) CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Springhill Fund Asset Management (Hk) CO LTD with notifications on news.